IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Date	Title
04/02/2003	Enbrel (etanercept) - Important safety information from Wyeth as approved by the Irish Medicines Board
03/06/2005	Electronic Submission Declaration
01/01/2007	Eudralex Volume 1 - Pharmaceutical legislation - Medicinal Products for Human Use
23/05/2007	Exjade (deferasirox) Tablets - Important Safety Information from Novartis as approved by the Irish Medicines Board
29/08/2007	Extraneal (Icodextrin 7.5%) - Important Safety Information from Baxter Healthcare as approved by the Irish Medicines Board
01/11/2007	Exubera (Insulin human [DNA origin]) Inhalation Powder) - Important Safety Information from Pfizer as approved by the Irish Medicines Board
10/07/2008	Exjade (deferasirox)-Important Safety Information from Novartis as approved by the IMB
05/06/2009	Exenatide (Byetta) – Risk of severe pancreatitis and warnings regarding use in renal impairment
11/08/2009	EFIENT® (prasugrel) - Important Safety Information from Danchii-Sankyo and Lilly as approved by the Irish Medicines Board
09/09/2009	Endoscopy Endofal Aimers - Important Safety Information from Smith & Nephew Endoscopy
04/05/2010	Exelon / Prometax (rivastigmine) - Important Safety Information from Novartis as approved by the Irish Medicines Board
10/09/2010	EVICEL Solutions for Sealant (Human) products - Important Safety Information from Omrix Biopharmaceuticals Ltd. and Ethicon, Inc. as approved by the Irish Medicines Board
29/10/2010	Ebixa memantine hydrochloride oral solution - Important Safety Information from Lundbeck as approved by the Irish Medicines Board
07/04/2011	Efient (prasugrel) - Important Safety Information from Daiichi Sankyo and Lilly as approved by the Irish Medicines Board